HXCK Fundamental Analysis - ERNST RUSS AG

Fundamental Rating

Overall HXCK gets a fundamental rating of 7 out of 10. We evaluated HXCK against 121 industry peers in the Capital Markets industry. Both the health and profitability get an excellent rating, making HXCK a very profitable company, without any liquidiy or solvency issues. HXCK is valued quite cheap, but it does not seem to be growing. With these ratings, HXCK could be worth investigating further for value investing!.

Quickly go to:

1. Profitability

1.1 Basic Checks

HXCK had positive earnings in the past year.
HXCK had positive earnings in each of the past 5 years.
Each year in the past 5 years HXCK had a positive operating cash flow.

1.2 Ratios

HXCK's Return On Assets of 28.42% is amongst the best of the industry. HXCK outperforms 99.21% of its industry peers.
The Return On Equity of HXCK (42.91%) is better than 95.28% of its industry peers.
The Return On Invested Capital of HXCK (10.85%) is better than 86.61% of its industry peers.
HXCK had an Average Return On Invested Capital over the past 3 years of 18.48%. This is significantly above the industry average of 8.43%.
The 3 year average ROIC (18.48%) for HXCK is well above the current ROIC(10.85%). The reason for the recent decline needs to be investigated.

		Industry Rank	Sector Rank
ROA	28.42%
ROE	42.91%
ROIC	10.85%

ROA(3y)14.95%

ROA(5y)10.67%

ROE(3y)31.94%

ROE(5y)24.94%

ROIC(3y)18.48%

ROIC(5y)13.46%

1.3 Margins

HXCK has a Profit Margin of 39.98%. This is amongst the best in the industry. HXCK outperforms 85.04% of its industry peers.
HXCK's Profit Margin has improved in the last couple of years.
The Operating Margin of HXCK (19.84%) is better than 61.42% of its industry peers.
HXCK's Operating Margin has improved in the last couple of years.
HXCK has a Gross Margin (35.90%) which is comparable to the rest of the industry.
HXCK's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	19.84%
PM (TTM)	39.98%
GM	35.9%

OM growth 3Y-2.94%

OM growth 5Y22.67%

PM growth 3Y12.88%

PM growth 5Y56.93%

GM growth 3Y2.91%

GM growth 5Y3.19%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for HXCK has been increased compared to 1 year ago.
Compared to 5 years ago, HXCK has more shares outstanding
Compared to 1 year ago, HXCK has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.47 indicates that HXCK is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.47, HXCK belongs to the top of the industry, outperforming 81.89% of the companies in the same industry.
HXCK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	3.47

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 4.10 indicates that HXCK has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.10, HXCK belongs to the best of the industry, outperforming 88.98% of the companies in the same industry.
A Quick Ratio of 4.05 indicates that HXCK has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.05, HXCK belongs to the best of the industry, outperforming 89.76% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	4.1
Quick Ratio	4.05

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

HXCK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -23.32%.
Measured over the past years, HXCK shows a very strong growth in Earnings Per Share. The EPS has been growing by 93.23% on average per year.
HXCK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.78%.
The Revenue has been growing by 24.05% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-23.32%

EPS 3Y37.36%

EPS 5Y93.23%

EPS Q2Q%101.83%

Revenue 1Y (TTM)-14.78%

Revenue growth 3Y23.24%

Revenue growth 5Y24.05%

Sales Q2Q%-6.19%

3.2 Future

HXCK is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -23.99% yearly.
The Revenue is expected to decrease by -4.22% on average over the next years.

EPS Next Y57.97%

EPS Next 2Y-8.63%

EPS Next 3Y-23.99%

EPS Next 5YN/A

Revenue Next Year-4.77%

Revenue Next 2Y-5.56%

Revenue Next 3Y-6.66%

Revenue Next 5Y-4.22%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 2.44, the valuation of HXCK can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of HXCK indicates a rather cheap valuation: HXCK is cheaper than 100.00% of the companies listed in the same industry.
HXCK's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.38.
The Price/Forward Earnings ratio is 7.23, which indicates a rather cheap valuation of HXCK.
Based on the Price/Forward Earnings ratio, HXCK is valued cheaper than 98.43% of the companies in the same industry.
HXCK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.29.

		Industry Rank	Sector Rank
PE	2.44
Fwd PE	7.23

4.2 Price Multiples

96.85% of the companies in the same industry are more expensive than HXCK, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	1.74

4.3 Compensation for Growth

HXCK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of HXCK may justify a higher PE ratio.
A cheap valuation may be justified as HXCK's earnings are expected to decrease with -23.99% in the coming years.

PEG (NY)0.04

PEG (5Y)0.03

EPS Next 2Y-8.63%

EPS Next 3Y-23.99%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

HXCK has a Yearly Dividend Yield of 2.87%. Purely for dividend investing, there may be better candidates out there.
HXCK's Dividend Yield is a higher than the industry average which is at 3.07.
Compared to an average S&P500 Dividend Yield of 1.85, HXCK pays a better dividend.

		Industry Rank	Sector Rank
Dividend Yield	2.87%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years1

Div Non Decr Years1

5.3 Sustainability

HXCK pays out 116.31% of its income as dividend. This is not a sustainable payout ratio.

DP116.31%

EPS Next 2Y-8.63%

EPS Next 3Y-23.99%

More info and screens

Find the best dividend stocks

Show peers with best dividend

ERNST RUSS AG

FRA:HXCK (1/7/2026, 7:00:00 PM)

7.08

-0.22 (-3.01%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)11-11 2025-11-11

Earnings (Next)03-23 2026-03-23

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap238.53M

Revenue(TTM)245.35M

Net Income(TTM)98.08M

Analysts84.44

Price Target11.22 (58.47%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	2.87%

Yearly Dividend1.42

Dividend Growth(5Y)N/A

DP116.31%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)6.45%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)14.98%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)1.82%

Valuation

		Industry Rank	Sector Rank
PE	2.44
Fwd PE	7.23
P/S	0.97
P/FCF	N/A
P/OCF	N/A
P/B	1.04
P/tB	1.05
EV/EBITDA	1.74

EPS(TTM)2.9

EY40.96%

EPS(NY)0.98

Fwd EY13.83%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS7.28

BVpS6.78

TBVpS6.77

PEG (NY)0.04

PEG (5Y)0.03

Graham Number21.04

Profitability

		Industry Rank	Sector Rank
ROA	28.42%
ROE	42.91%
ROCE	15.41%
ROIC	10.85%
ROICexc	16.64%
ROICexgc	16.67%
OM	19.84%
PM (TTM)	39.98%
GM	35.9%
FCFM	N/A

ROA(3y)14.95%

ROA(5y)10.67%

ROE(3y)31.94%

ROE(5y)24.94%

ROIC(3y)18.48%

ROIC(5y)13.46%

ROICexc(3y)25.45%

ROICexc(5y)17.96%

ROICexgc(3y)25.68%

ROICexgc(5y)18.15%

ROCE(3y)26.25%

ROCE(5y)19.12%

ROICexgc growth 3Y17.82%

ROICexgc growth 5Y38.89%

ROICexc growth 3Y18.34%

ROICexc growth 5Y40.48%

OM growth 3Y-2.94%

OM growth 5Y22.67%

PM growth 3Y12.88%

PM growth 5Y56.93%

GM growth 3Y2.91%

GM growth 5Y3.19%

F-ScoreN/A

Asset Turnover0.71

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	0
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	4.1
Quick Ratio	4.05
Altman-Z	3.47

F-ScoreN/A

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)131.41%

Cap/Depr(5y)138.09%

Cap/Sales(3y)22.8%

Cap/Sales(5y)22.04%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-23.32%

EPS 3Y37.36%

EPS 5Y93.23%

EPS Q2Q%101.83%

EPS Next Y57.97%

EPS Next 2Y-8.63%

EPS Next 3Y-23.99%

EPS Next 5YN/A

Revenue 1Y (TTM)-14.78%

Revenue growth 3Y23.24%

Revenue growth 5Y24.05%

Sales Q2Q%-6.19%

Revenue Next Year-4.77%

Revenue Next 2Y-5.56%

Revenue Next 3Y-6.66%

Revenue Next 5Y-4.22%

EBIT growth 1Y-29.7%

EBIT growth 3Y19.62%

EBIT growth 5Y52.17%

EBIT Next Year102.82%

EBIT Next 3Y-7.07%

EBIT Next 5Y-1.63%

FCF growth 1Y1292.57%

FCF growth 3Y38.27%

FCF growth 5YN/A

OCF growth 1Y9.2%

OCF growth 3Y35.91%

OCF growth 5Y51.72%

ERNST RUSS AG / HXCK.DE FAQ

What is the ChartMill fundamental rating of ERNST RUSS AG (HXCK.DE) stock?

ChartMill assigns a fundamental rating of 7 / 10 to HXCK.DE.

Can you provide the valuation status for ERNST RUSS AG?

ChartMill assigns a valuation rating of 8 / 10 to ERNST RUSS AG (HXCK.DE). This can be considered as Undervalued.

What is the profitability of HXCK stock?

ERNST RUSS AG (HXCK.DE) has a profitability rating of 9 / 10.

What are the PE and PB ratios of ERNST RUSS AG (HXCK.DE) stock?

The Price/Earnings (PE) ratio for ERNST RUSS AG (HXCK.DE) is 2.44 and the Price/Book (PB) ratio is 1.04.

Can you provide the expected EPS growth for HXCK stock?

The Earnings per Share (EPS) of ERNST RUSS AG (HXCK.DE) is expected to grow by 57.97% in the next year.

ERNST RUSS AG (HXCK.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

ERNST RUSS AG / HXCK.DE FAQ

What is the ChartMill fundamental rating of ERNST RUSS AG (HXCK.DE) stock?

Can you provide the valuation status for ERNST RUSS AG?

What is the profitability of HXCK stock?

What are the PE and PB ratios of ERNST RUSS AG (HXCK.DE) stock?

Can you provide the expected EPS growth for HXCK stock?